Article Text

Download PDFPDF

Asthma exacerbations · 3: Pathogenesis
  1. P A B Wark,
  2. P G Gibson
  1. Department of Respiratory and Sleep Medicine, Hunter Medical Research Institute, University of Newcastle, and John Hunter Hospital, Newcastle, NSW 2310, Australia
  1. Correspondence to:
    Professor P G Gibson
    Department of Respiratory and Sleep Medicine, Hunter Medical Research Institute, Locked Bag 1, Hunter Region Mail Centre, NSW 2310 Australia; Peter.Gibson{at}hnehealth.nsw.gov.au

Footnotes

  • Supported by NHMRC Australia, Hunter Medical Research Institute, and New South Wales Health.

  • Competing interests: The authors have participated in clinical trials of asthma therapies funded by GlaxoSmithKline, AstraZeneca, Pharmaxis, Aventis, Novartis and NHMRC Australia.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Supported by NHMRC Australia, Hunter Medical Research Institute, and New South Wales Health.

  • Competing interests: The authors have participated in clinical trials of asthma therapies funded by GlaxoSmithKline, AstraZeneca, Pharmaxis, Aventis, Novartis and NHMRC Australia.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.